Multicenter study of circulating tumor DNA in patients with pancreatic cancer using a personalized panel: ARTEMIS-PC prospective observational trial.

Authors

Edward Esplin

Edward D. Esplin

Invitae, San Francisco, CA

Edward D. Esplin , Taro Shibuki , Hideaki Bando , Makoto Ueno , Takuji Okusaka , Ippei Matsumoto , Kenji Ikezawa , Yoshito Komatsu , Michiaki Unno , Teiichi Sugiura , Masayuki Furukawa , Kelli Swan , Emily Westheimer , Keir Violaceae , Chiharu Graybill , Robert Daber , W. Michael Korn , Takayuki Yoshino , Masafumi Ikeda

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Tumor Biology, Biomarkers, and Pathology

Clinical Trial Registration Number

NCT06043921

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr TPS721)

DOI

10.1200/JCO.2024.42.3_suppl.TPS721

Abstract #

TPS721

Poster Bd #

Q10

Abstract Disclosures

Similar Posters

First Author: Lei Deng

Poster

2020 Gastrointestinal Cancers Symposium

Detection of circulating tumor DNA in pancreas cancer.

Detection of circulating tumor DNA in pancreas cancer.

First Author: Daniel King

Poster

2020 Gastrointestinal Cancers Symposium

Clinical significance of monitoring <em>KRAS </em>in tissue and plasma of pancreatic cancer patients.

Clinical significance of monitoring KRAS in tissue and plasma of pancreatic cancer patients.

First Author: Fumiaki Watanabe